These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 23638013)

  • 1. Longitudinal MRI evaluation of intracranial development and vascular characteristics of breast cancer brain metastases in a mouse model.
    Zhou H; Chen M; Zhao D
    PLoS One; 2013; 8(4):e62238. PubMed ID: 23638013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MRI evaluation of the effects of whole brain radiotherapy on breast cancer brain metastasis.
    Crowe W; Wang L; Zhang Z; Varagic J; Bourland JD; Chan MD; Habib AA; Zhao D
    Int J Radiat Biol; 2019 Mar; 95(3):338-346. PubMed ID: 30499763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential for differentiation of pseudoprogression from true tumor progression with dynamic susceptibility-weighted contrast-enhanced magnetic resonance imaging using ferumoxytol vs. gadoteridol: a pilot study.
    Gahramanov S; Raslan AM; Muldoon LL; Hamilton BE; Rooney WD; Varallyay CG; Njus JM; Haluska M; Neuwelt EA
    Int J Radiat Oncol Biol Phys; 2011 Feb; 79(2):514-23. PubMed ID: 20395065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ultrasound imaging-guided intracardiac injection to develop a mouse model of breast cancer brain metastases followed by longitudinal MRI.
    Zhou H; Zhao D
    J Vis Exp; 2014 Mar; (85):. PubMed ID: 24637963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamic susceptibility contrast (DSC) perfusion MRI in differential diagnosis between radionecrosis and neoangiogenesis in cerebral metastases using rCBV, rCBF and K2.
    Muto M; Frauenfelder G; Senese R; Zeccolini F; Schena E; Giurazza F; Jäger HR
    Radiol Med; 2018 Jul; 123(7):545-552. PubMed ID: 29508242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Magnetic resonance imaging-based tumour perfusion parameters are biomarkers predicting response after radiation to brain metastases.
    Jakubovic R; Sahgal A; Soliman H; Milwid R; Zhang L; Eilaghi A; Aviv RI
    Clin Oncol (R Coll Radiol); 2014 Nov; 26(11):704-12. PubMed ID: 25023291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation of relative permeability and relative cerebral blood volume in high-grade cerebral neoplasms.
    Provenzale JM; York G; Moya MG; Parks L; Choma M; Kealey S; Cole P; Serajuddin H
    AJR Am J Roentgenol; 2006 Oct; 187(4):1036-42. PubMed ID: 16985154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase contrast MRI is an early marker of micrometastatic breast cancer development in the rat brain.
    Budde MD; Gold E; Jordan EK; Smith-Brown M; Frank JA
    NMR Biomed; 2012 May; 25(5):726-36. PubMed ID: 21954124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamic contrast-enhanced susceptibility-weighted perfusion imaging of intracranial tumors: a study using a 3T MR scanner.
    Sentürk S; Oğuz KK; Cila A
    Diagn Interv Radiol; 2009 Mar; 15(1):3-12. PubMed ID: 19263367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rat model of metastatic breast cancer monitored by MRI at 3 tesla and bioluminescence imaging with histological correlation.
    Song HT; Jordan EK; Lewis BK; Liu W; Ganjei J; Klaunberg B; Despres D; Palmieri D; Frank JA
    J Transl Med; 2009 Oct; 7():88. PubMed ID: 19840404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Half brain irradiation in a murine model of breast cancer brain metastasis: magnetic resonance imaging and histological assessments of dose-response.
    Zarghami N; Murrell DH; Jensen MD; Dick FA; Chambers AF; Foster PJ; Wong E
    Radiat Oncol; 2018 Jun; 13(1):104. PubMed ID: 29859114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Voxel-based evidence of perfusion normalization in glioblastoma patients included in a phase I-II trial of radiotherapy/tipifarnib combination.
    Ken S; Deviers A; Filleron T; Catalaa I; Lotterie JA; Khalifa J; Lubrano V; Berry I; Péran P; Celsis P; Moyal EC; Laprie A
    J Neurooncol; 2015 Sep; 124(3):465-73. PubMed ID: 26189058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perfusion MRI (dynamic susceptibility contrast imaging) with different measurement approaches for the evaluation of blood flow and blood volume in human gliomas.
    Thomsen H; Steffensen E; Larsson EM
    Acta Radiol; 2012 Feb; 53(1):95-101. PubMed ID: 22114021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Relative Cerebral Blood Volume from Dynamic Susceptibility Contrast-Enhanced Perfusion MR with HER2 Status in Breast Cancer Brain Metastases.
    Young JR; Ressler JA; Shiroishi MS; Mortimer JE; Schmolze D; Fitzgibbons M; Chen BT
    Acad Radiol; 2023 Sep; 30(9):1816-1822. PubMed ID: 36549990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Malignancy assessment of brain tumours with magnetic resonance spectroscopy and dynamic susceptibility contrast MRI.
    Fayed N; Dávila J; Medrano J; Olmos S
    Eur J Radiol; 2008 Sep; 67(3):427-33. PubMed ID: 18442889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo characterization of changing blood-tumor barrier permeability in a mouse model of breast cancer metastasis: a complementary magnetic resonance imaging approach.
    Percy DB; Ribot EJ; Chen Y; McFadden C; Simedrea C; Steeg PS; Chambers AF; Foster PJ
    Invest Radiol; 2011 Nov; 46(11):718-25. PubMed ID: 21788908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Probabilistic independent component analysis of dynamic susceptibility contrast perfusion MRI in metastatic brain tumors.
    Chakhoyan A; Raymond C; Chen J; Goldman J; Yao J; Kaprealian TB; Pouratian N; Ellingson BM
    Cancer Imaging; 2019 Mar; 19(1):14. PubMed ID: 30885275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of choline levels and tumor perfusion in brain metastases assessed with proton MR spectroscopy and dynamic susceptibility contrast-enhanced perfusion weighted MRI.
    Huang BY; Kwock L; Castillo M; Smith JK
    Technol Cancer Res Treat; 2010 Aug; 9(4):327-37. PubMed ID: 20626199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In-vivo longitudinal MRI study: an assessment of melanoma brain metastases in a clinically relevant mouse model.
    Henry MN; Chen Y; McFadden CD; Simedrea FC; Foster PJ
    Melanoma Res; 2015 Apr; 25(2):127-37. PubMed ID: 25513779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-grade gliomas: do changes in rCBV measurements at longitudinal perfusion-weighted MR imaging predict malignant transformation?
    Danchaivijitr N; Waldman AD; Tozer DJ; Benton CE; Brasil Caseiras G; Tofts PS; Rees JH; Jäger HR
    Radiology; 2008 Apr; 247(1):170-8. PubMed ID: 18372467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.